Huisheng Biotech announced that the controlling shareholder, Wuhan Tongsheng Investment Co., Ltd., plans to transfer no more than 4 million shares of the company to Ms. Yu Jiaoe, one of the actual controllers, from October 9, 2026 to January 8, 2027, in bulk transactions, accounting for 1.98% of the total share capital of the company and 2.00% of the total share capital excluding the repurchased shares. This is an internal transfer between the controlling shareholder and actual controller, and will not result in a change in the company's control.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.